Clinical Trials Logo
  1. Home
  2. Behavior Therapy
  3. NCT00102349
  4. Details
NCT00102349 Clinical Trial

HIV and HCV Intervention In Drug Treatment Settings - 1

Behavior Therapy Clinical Trial

Official title:
HIV and HCV Intervention in Drug Treatment Settings

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00102349
Other study ID # NIDA-CTN-0017-1
Secondary ID
Status Completed
Phase Phase 3
First received January 27, 2005
Last updated January 11, 2017
Start date November 2004
Est. completion date February 2006

Study information
Verified date October 2016
Source National Institute on Drug Abuse (NIDA)
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

The purpose of this study is to test two strategies to reduce the risk of contracting Human Immunodeficiency Virus (HIV) or Hepatitis C Virus (HCV) by reducing risk behaviors in patients undergoing drug detoxification.

Recruitment information / eligibility
Status Completed
Enrollment 706
Est. completion date February 2006
Est. primary completion date February 2006
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Volunteers will be IV drug users already enrolled in drug detoxification treatment.

Study Design

Primary Purpose: Prevention

Related Conditions & MeSH terms

Intervention

Behavioral:
• Behavior Therapy

Locations
Country Name City State
United States Denver Health & Hosp Authority Denver Colorado
United States Willamette Family Treatment Services Eugene Oregon
United States SSTAR (Stanley St. Treatment & Resources, Inc) Fall River Massachusetts
United States Island Grove RTC Greeley Colorado
United States James Gilmore Jr. Treatment Center Kalamazoo Michigan
United States Recovery Center King Co.-Kent Detox Kent Washington
United States SSTAR of Rhode Island - North Kingstown North Kingstown Rhode Island
United States Recovery Center King Co.-Seattle Detox Seattle Washington

Sponsors (2)
Lead Sponsor Collaborator
University of Colorado, Denver Oregon Health and Science University

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary HIV/HCV injection risk behaviors
See also
  Status Clinical Trial Phase
Completed NCT03443323 - Organizational Skills Training N/A
Completed NCT02535598 - Therapy Labs: To Improve Adherence in Internet Based Psychotherapy N/A
Completed NCT00084188 - HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs - 1 Phase 3
Completed NCT00158288 - The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1 Phase 2
Completed NCT04420533 - Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron in Sexually Active Men With OAB Symptoms N/A
Recruiting NCT01365026 - PVS: Innovative Programs For Healthy Lifestyle Promotion in Primary Care: 'Prescribe Healthy Life' N/A
Completed NCT03001154 - Virtual Reality Exposure Therapy for Speech Anxiety Using Commercial Hardware and Software N/A
Not yet recruiting NCT06260020 - Development and Validation of a Comprehensive Module for Management of Sleep Disorders in ASD Children N/A
Completed NCT04235582 - Incentives to Decrease Opioid Use - Pilot N/A
Active, not recruiting NCT01318538 - Recovery Group for Women With Substance Use Disorders Phase 2
Completed NCT00084175 - HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs - 1 Phase 3